Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis.
Celestine M TrinidadCarlos A Torres-CabalaVictor G PrietoLeomar Y BallesterPublished in: Journal of clinical pathology (2019)
Merkel cell carcinoma (MCC) is a rare primary cutaneous neuroendocrine carcinoma. The annual incidence of MCC is increasing in the USA. Timely diagnosis and proper staging of this tumour are crucial as MCC has high rates of regional recurrence and lymph node and distant metastasis. In this review, we outline the key differences between the tumor node metastasis (TNM) staging criteria for MCC in the seventh and eighth editions of the AJCC Cancer Staging Manual We also discuss histopathological parameters that are not included in the eighth edition of the manual but have been shown in other studies to predict a worse prognosis in patients with MCC. Correct assessment and reporting of these clinically relevant histopathological parameters is of utmost importance for practising pathologists as management differs according to the stage of the tumour. This review aims to increase awareness of all these parameters, and proper recognition would guide the treating clinicians towards the most appropriate treatment options that can be given to patients.
Keyphrases
- lymph node
- papillary thyroid
- sentinel lymph node
- neoadjuvant chemotherapy
- end stage renal disease
- squamous cell
- pet ct
- ejection fraction
- chronic kidney disease
- machine learning
- newly diagnosed
- deep learning
- prognostic factors
- squamous cell carcinoma
- palliative care
- emergency department
- peritoneal dialysis
- early stage
- rectal cancer